121
Views
11
CrossRef citations to date
0
Altmetric
Review

Immunomodulatory drug treatment in multiple sclerosis

Pages 1423-1436 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (10)

Rachel E Brimelow. (2017) Modifying therapies for the treatment of relapse-remitting multiple sclerosis. British Journal of Healthcare Management 23:10, pages 468-476.
Crossref
Rachel E Brimelow. (2017) Disease modifying therapies for the treatment of relapse-remitting multiple sclerosis. Nurse Prescribing 15:5, pages 222-228.
Crossref
Renana From, Raya Eilam, Dekel D. Bar-Lev, Smadar Levin-Zaidman, Michael Tsoory, Patrizia LoPresti, Michael Sela, Ruth Arnon & Rina Aharoni. (2014) Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate. Glia 62:4, pages 649-665.
Crossref
Paula Pifarré, María Gutierrez-Mecinas, Judith Prado, Lorena Usero, Carme Roura-Mir, Mercedes Giralt, Juan Hidalgo & Agustina García. (2014) Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions. Experimental Neurology 251, pages 58-71.
Crossref
Rina Aharoni, Efrat Sasson, Tamar Blumenfeld-Katzir, Raya Eilam, Michael Sela, Yaniv Assaf & Ruth Arnon. (2013) Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate. Experimental Neurology 240, pages 130-144.
Crossref
Christian Hölscher. (2012) Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection. CNS Drugs 26:10, pages 871-882.
Crossref
Djordje Miljković, Gordana Timotijević & Marija Mostarica Stojković. (2011) Astrocytes in the tempest of multiple sclerosis. FEBS Letters 585:23, pages 3781-3788.
Crossref
Rina Aharoni, Anya Vainshtein, Ariel Stock, Raya Eilam, Renana From, Vera Shinder & Ruth Arnon. (2011) Distinct pathological patterns in relapsing–remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate. Journal of Autoimmunity 37:3, pages 228-241.
Crossref
Jenny Lam & Heike Wulff. (2011) The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression. Drug Development Research 72:7, pages 573-584.
Crossref
. (2011) Current World Literature. Current Opinion in Neurology 24:3, pages 300-307.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.